Inspire Medical Systems Inc (INSP)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | -19,906 | -44,268 | -41,970 | -57,088 | -33,203 |
Revenue | US$ in thousands | 624,799 | 406,179 | 231,266 | 113,364 | 82,050 |
Pretax margin | -3.19% | -10.90% | -18.15% | -50.36% | -40.47% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $-19,906K ÷ $624,799K
= -3.19%
The pretax margin of Inspire Medical Systems Inc has shown improvement over the past five years. The company's pretax margin was -3.19% in 2023, an improvement from the negative margins in the previous years, such as -10.90% in 2022, -18.15% in 2021, -50.36% in 2020, and -40.47% in 2019. This indicates that the company has been able to effectively manage its expenses relative to its revenue, leading to a smaller loss before taxes in the most recent year. However, it is important to monitor this trend closely to ensure sustained profitability in the future.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
Inspire Medical Systems Inc
INSP
-3.19%
3M Company
MMM
-29.64%
Artivion Inc
AORT
-6.52%
Baxter International Inc
BAX
17.66%
Becton Dickinson and Company
BDX
9.94%
Boston Scientific Corp
BSX
14.20%
DexCom Inc
DXCM
19.72%
Embecta Corp
EMBC
3.95%
Glaukos Corp
GKOS
-44.40%
Globus Medical
GMED
10.54%
Haemonetics Corporation
HAE
5.85%